1. Home
  2. PLXS vs HAE Comparison

PLXS vs HAE Comparison

Compare PLXS & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLXS
  • HAE
  • Stock Information
  • Founded
  • PLXS 1979
  • HAE 1971
  • Country
  • PLXS United States
  • HAE United States
  • Employees
  • PLXS N/A
  • HAE N/A
  • Industry
  • PLXS Electrical Products
  • HAE Medical/Dental Instruments
  • Sector
  • PLXS Technology
  • HAE Health Care
  • Exchange
  • PLXS Nasdaq
  • HAE Nasdaq
  • Market Cap
  • PLXS 3.7B
  • HAE 3.7B
  • IPO Year
  • PLXS 1986
  • HAE 1991
  • Fundamental
  • Price
  • PLXS $145.11
  • HAE $80.56
  • Analyst Decision
  • PLXS Buy
  • HAE Strong Buy
  • Analyst Count
  • PLXS 4
  • HAE 9
  • Target Price
  • PLXS $157.50
  • HAE $79.67
  • AVG Volume (30 Days)
  • PLXS 171.4K
  • HAE 1.2M
  • Earning Date
  • PLXS 10-22-2025
  • HAE 11-06-2025
  • Dividend Yield
  • PLXS N/A
  • HAE N/A
  • EPS Growth
  • PLXS 56.11
  • HAE 42.54
  • EPS
  • PLXS 6.26
  • HAE 3.44
  • Revenue
  • PLXS $4,032,966,000.00
  • HAE $1,327,850,000.00
  • Revenue This Year
  • PLXS $10.81
  • HAE N/A
  • Revenue Next Year
  • PLXS $7.18
  • HAE $6.35
  • P/E Ratio
  • PLXS $22.98
  • HAE $23.51
  • Revenue Growth
  • PLXS 1.82
  • HAE N/A
  • 52 Week Low
  • PLXS $103.43
  • HAE $47.32
  • 52 Week High
  • PLXS $172.89
  • HAE $89.69
  • Technical
  • Relative Strength Index (RSI)
  • PLXS 55.07
  • HAE 90.02
  • Support Level
  • PLXS $132.03
  • HAE $71.91
  • Resistance Level
  • PLXS $142.35
  • HAE $81.83
  • Average True Range (ATR)
  • PLXS 5.04
  • HAE 2.50
  • MACD
  • PLXS 0.27
  • HAE 0.81
  • Stochastic Oscillator
  • PLXS 85.59
  • HAE 91.36

About PLXS Plexus Corp.

Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: